Studies on antidiabetic effects of cortex Moutan polysaccharide-2b in type 2 diabetes mellitus rats / 药学学报

<p><b>AIM</b>To study the antidiabetic effects of cortex Moutan polysaccharide-2b (CMP-2b) in type 2 diabetes mellitus (T2DM) rats.</p><p><b>METHODS</b>The T2DM model rats were induced by a single intravenous injection of low dose streptozotocin (STZ) and intake of high sucrose-fat diet. CMP-2b was given to T2DM rats daily through gavage for 4-5 weeks. The body weight, water and food intake, fasting blood glucose (FBG), glucose tolerance, plasma lipids, serum insulin, and insulin receptor (Ins R) were determined.</p><p><b>RESULTS</b>Oral administration of CMP-2b significantly decreased water and food intake, FBG, total cholesterol (Tch), and triglyceride (TG), improved the impaired glucose tolerance (IGT), and remarkably raised the number of low affinity InsR and insulin sensitivity index (ISI) in T2DM rats.</p><p><b>CONCLUSION</b>CMP-2b may be useful for treating T2DM and its complications.</p>

Protective effect of ligustrazine on insulin resistance after local cerebral ischemia of rat / 中国中药杂志

<p><b>OBJECTIVE</b>To study the protective effect of Ligustrazine on IR after local cerebral ischemia of rat.</p><p><b>METHOD</b>Models of rat IR after local cerebral ischemia were prepared by electrocagulation of the middle cerebral artery, and changes of serum insulin, tomer necrosis factor-alpha (TNF-alpha), plasma endothelin-1 (ET-1), nitric oxide (NO) and nitric oxide synthase (NOS) were observed 2 weeks after the ischemia.</p><p><b>RESULT</b>Ligustrazine could significantly reduce serum insulin (P < 0.01), the content of plasma ET-1 (P < 0.01) and serum TNF-alpha (P < 0.01), the activity of brain tissue NO and NOS (P < 0.01). The drug also increased insulin sensitivity indexes (ISI).</p><p><b>CONCLUSION</b>The protective effects of Ligustrazion on IR cerebral ischemia may be related to decreasing ET-1 content in plasma, TNF-alpha content in serum, NO content and NOS activities in tissue.</p>